Ionis Pharma (IONS) Misses Q1 EPS by 2c

Ionis Pharma (NASDAQ: IONS) reported Q1 EPS of $0.03, $0.02 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $110.3 million versus the consensus estimate of $116.45 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• Ionis Pharmaceuticals (IONS) PT Raised to $130 at H.C. Wainwright
• McCormick & Co. (MKC) Tops Q2 EPS by 10c ; Offers Guidance
• Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance